Antifibrotic properties of receptor for advanced glycation end products in idiopathic pulmonary fibrosis | |
Ding, Hui[1]; Ji, XiuHai[2]; Chen, Ruhua[3]; Ma, Tieliang[4]; Tang, Zhiwei[5]; Fen, Yan[6]; Cai, Hourong[7] | |
刊名 | PULMONARY PHARMACOLOGY & THERAPEUTICS |
2015 | |
卷号 | 35页码:34-41 |
关键词 | RAGE EMT IPF TGF-beta 1 ERK |
ISSN号 | 1094-5539 |
DOI | http://dx.doi.org/10.1016/j.pupt.2015.10.010 |
URL标识 | 查看原文 |
收录类别 | SCI(E) ; PUBMED |
WOS记录号 | WOS:000367498100006 |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/5389111 |
专题 | 江苏大学 |
作者单位 | 1.[1]Jiangsu Univ, Affiliated Yixing People Hosp, Dept Pulm Med, Zhenjiang 214200, Jiangsu, Peoples R China. 2.[2]Affiliated Taicang Hosp Tradit Chinese Med, Dept Oncol, Suzhou, Peoples R China. 3.[3]Jiangsu Univ, Affiliated Yixing People Hosp, Dept Pulm Med, Zhenjiang 214200, Jiangsu, Peoples R China. 4.[4]Jiangsu Univ, Affiliated Yixing People Hosp, Dept Pulm Med, Zhenjiang 214200, Jiangsu, Peoples R China. 5.[5]Jiangsu Univ, Affiliated Yixing People Hosp, Dept Pulm Med, Zhenjiang 214200, Jiangsu, Peoples R China. 6.[6]Jiangsu Univ, Affiliated Yixing People Hosp, Dept Pulm Med, Zhenjiang 214200, Jiangsu, Peoples R China. 7.[7]Nanjing Univ, Sch Med, Affiliated Hosp, Dept Resp Med,Nanjing Drum Tower Hosp, Nanjing 210029, Jiangsu, Peoples R China. |
推荐引用方式 GB/T 7714 | Ding, Hui[1],Ji, XiuHai[2],Chen, Ruhua[3],et al. Antifibrotic properties of receptor for advanced glycation end products in idiopathic pulmonary fibrosis[J]. PULMONARY PHARMACOLOGY & THERAPEUTICS,2015,35:34-41. |
APA | Ding, Hui[1].,Ji, XiuHai[2].,Chen, Ruhua[3].,Ma, Tieliang[4].,Tang, Zhiwei[5].,...&Cai, Hourong[7].(2015).Antifibrotic properties of receptor for advanced glycation end products in idiopathic pulmonary fibrosis.PULMONARY PHARMACOLOGY & THERAPEUTICS,35,34-41. |
MLA | Ding, Hui[1],et al."Antifibrotic properties of receptor for advanced glycation end products in idiopathic pulmonary fibrosis".PULMONARY PHARMACOLOGY & THERAPEUTICS 35(2015):34-41. |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论